San Luis Obispo County residents responded to a survey sent by The Tribune about difficulties accessing primary care here in ...

Savita Dandapani, MD, PhD, discusses the rationale behind a study evaluating the combination of radium-223, hormone therapy, and SBRT in metastatic castration-sensitive prostate cancer.

Results of a study led by the Vall d'Hebron Institute of Oncology (VHIO) support the feasibility of using RAD51 testing to ...

The incidence rate of cases increased 6.7% per year on average between 2011 and 2021, the JAMA-published research revealed.

Advanced prostate cancer cases are rising sharply in California, outpacing national trends, according to a new study from ...

St. Bernards Medical Center is changing the game in treating prostate cancer with its new non-invasive treatment.

In Rwanda, cancer remains a leading health challenge, with breast, cervical, and prostate cancers being among the most prevalent. According to Dr. Theoneste Maniragaba, the Director of the Cancer ...

The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...

RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...

Northwell Staten Island University Hospital has announced the addition of the Focal One High-Intensity Focused Ultrasound ...

Radiotherapy, a standard of care treatment for localized prostate cancer includes, has shown remarkable success. This ...

Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious long-term urinary and bowel health issues, ...